gms | German Medical Science

129. Kongress der Deutschen Gesellschaft für Chirurgie

Deutsche Gesellschaft für Chirurgie

24.04. - 27.04.2012, Berlin

Transvaginal cholecystectomy – first randomized controlled trial

Meeting Abstract

  • Dietmar Borchert - DRK Krankenhaus, Chirurgie, Luckenwalde
  • Matthias Federlein - Sana Klinikum Berlin, Chirurgie, Berlin
  • Jens Burghardt - Ev. Freikirchliches Krankenhaus, Chirurgie, Rüdersdorf
  • Frauke Fritze - Sana Klinikum Berlin, Chirurgie, Berlin
  • Klaus Gellert - Sana Klinikum Berlin, Chirurgie, Berlin

Deutsche Gesellschaft für Chirurgie. 129. Kongress der Deutschen Gesellschaft für Chirurgie. Berlin, 24.-27.04.2012. Düsseldorf: German Medical Science GMS Publishing House; 2012. Doc12dgch026

doi: 10.3205/12dgch026, urn:nbn:de:0183-12dgch0268

Veröffentlicht: 23. April 2012

© 2012 Borchert et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Introduction: Transvaginal assisted cholecystectomy is a new approach to the abdominal cavity. It represents the transition of conventional laparoscopic and endoscopic surgery to a surgical approach using natural orifice access to the target organ. To date there are no randomized controlled trial availabe to compare transvaginal assisted cholecystectomy. We report the results of the first randomized controlled trial comparing conventional laparoscopic surgery with transvaginal assisted cholecystectomy.

Material and methods: Randomized double blind controlled trial comparing conventional laparoscopic with transvaginal assisted cholecystectomy. 44 patients are randomized in each group. Investigators are blinded to the surgical method used. Data collected include morbidity, ASA grade, BMI, age, laboratory data, surgical times, length of hospital stay, pain score, analgesic medication used, complications and health related quality of life using the SF-36 and GIQoL questionnaires with four week recall period.

Results: End of randomization is expected in 2011. We report the results of the first randomized double blind controlled trial of conventional laparoscopic versus transvaginal assisted cholecystectomy.